| Today's Open | $3.27 |
|---|---|
| Previous Close | $3.18 |
| Daily Range | $3.13 - $3.30 |
| 52-Week Range | $2.91 - $8.18 |
| Market Cap | $35.4M |
| P/E Ratio | -1.25 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 796,807 |
| Average Daily Volume | 290,194 |
| Current FY EPS | $0.00 |
Sector
Healthcare
Industry
Drugs
CYCLACEL PHARMACEUTICALS, INC. (CYCC) Description
A development-stage biopharmaceutical company dedicated to the discovery, development and eventual commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Website: http://www.cyclacel.com/
News & Commentary
Insiders at Lululemon and Restoration Hardware Sell Company Stock
Plus, there were noteworthy purchases at Ambit Biosciences and Cyclacel Pharmaceuticals.Cyclacel Announces New Stock Issue
The pharmaceutical company hopes to reap gross proceeds of around $20 million from the offering.CYCC's Top Competitors
(2.20%)
(0.27%)
(0.59%)
(1.13%)